1-Test Cyp 100 mg

1-Test Cyp 100 mg contains dihydroboldenone cypionate, a potent non-aromatizing injectable anabolic steroid. It is not approved for medical use. In non-medical bodybuilding contexts, it is commonly referenced for lean, dry muscle gains and recomposition without water retention or estrogenic side effects, though such use falls outside approved indications.

Because of its cypionate ester, dihydroboldenone has a half-life of approximately 8 to 12 days and is typically referenced as being administered twice weekly in non-medical contexts. This extended release profile allows for less frequent injections compared to the acetate form.

Yes. Dihydroboldenone is profoundly suppressive to endogenous testosterone production, and full HPTA shutdown is expected. In non-medical bodybuilding contexts, post-cycle therapy with SERMs such as Clomid or Nolvadex is commonly referenced, typically starting 2.5 to 3 weeks after the final injection due to the ester's clearance time.

Dihydroboldenone is a potent anabolic steroid that binds selectively to the androgen receptor and stimulates AR-dependent transactivation. It is not aromatized to estrogen, so it does not cause water retention or gynecomastia through that pathway. In vivo studies show it has high anabolic and androgenic potency comparable to testosterone propionate.

With the cypionate ester, blood levels accumulate gradually. Early signs of improved recovery and slight increases in muscle fullness may become apparent by weeks 3 to 5, with anabolic effects becoming clearly visible by weeks 6 to 10 in non-medical contexts. Individual response varies.

There is no single injectable anabolic that is universally best. Dihydroboldenone offers potent, dry gains without aromatization, but it is also associated with significant post-injection pain and requires a testosterone base. Other compounds such as Masteron 100 and Cypionate 250 have different profiles and may be more appropriate depending on individual goals.

Dihydroboldenone is the 5-alpha reduced derivative of boldenone. Unlike boldenone, dihydroboldenone does not aromatize to estrogen, which means it does not cause water retention or estrogenic side effects through that pathway. Stacking the two together is generally considered pharmacologically redundant.

Both dihydroboldenone and Masteron (drostanolone) are non-aromatizing injectable anabolics with dry, lean profiles. Dihydroboldenone is generally considered more potent as an anabolic driver for new tissue growth, while Masteron is more commonly referenced for hardening and polish. Dihydroboldenone also has a longer half-life with the cypionate ester compared to Masteron propionate.

A single 100 mg dose represents a moderate amount when considering common non-medical reference ranges of 200 to 500 mg per week. Dihydroboldenone is noted to be extremely potent per milligram, with some users reporting noticeable effects at low doses. Individual response and tolerance vary.

1-Test Cyp 100 mg is labeled at 100 mg of dihydroboldenone cypionate per mL. It is supplied in a 10 mL vial, giving 1,000 mg of total labeled content per vial.

Laboratory testing information for 1-Test Cyp 100 mg is not currently available in this product listing. Dragon Pharma products are manufactured under pharmaceutical-grade conditions, but independent lab reports are not published for this specific product at this time.

Yes. Post-injection pain (PIP) is the defining side effect of dihydroboldenone, reported by the majority of users regardless of concentration, carrier oil, or injection technique. Pain typically begins 12 to 48 hours post-injection and can last 3 to 7 days, sometimes accompanied by redness, swelling, and warmth at the injection site. Formulation quality can influence this experience.